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1978Objectives: Current guidelines recommended surgery for patients with severe degenerative mitral regurgitation
(MR) when specific left ventricular (LV) dimensions or ejection fraction (EF) are reached, based on previous
postoperative survival studies. The aim of this study was to evaluate the incidence and predictors of
long-term postoperative LV dysfunction, and investigate the preoperative parameters necessary to maintain
or recover long-term LV function in the era of mitral valve (MV) repair.
Methods:We retrospectively reviewed 473 consecutive patients undergoing MV repair for severe degenerative
MR for whom both preoperative and 3-year postoperative echocardiographic data were available in our
institution. Preoperative and 3-year postoperative echocardiographic data and clinical outcomes were evaluated.
Results: Receiver operating characteristic analysis identified preoperative LVEF 63% or less (area under curve
[AUC], 0.725; P<.001) and LV end-systolic dimension (ESD) 39 mm or greater (AUC, 0.724; P<.001) as
cut-off values for predicting LVEF less than 50% 3 years after surgery. On multivariate analysis, both
preoperative LVEF and LVESD were not significant predictors of 3-year postoperative LV dysfunction among
patients with preoperative LVEF greater than 63% and LVESD less 39 mm, whereas preoperative LVESD
(odds ratio [OR], 2.22; P ¼ .004), higher age (OR, 1.03; P ¼ .04), and atrial fibrillation (OR, 2.68; P ¼ .01)
were independent predictors among patients with preoperative LVEF 63% or less or LVESD 39 mm or greater.
Conclusions: Early MV repair with LVEF greater than 63% and LVESD less than 39 mm preserved long-term
postoperative LV function well, and smaller preoperative LVESD was associated with long-term LV function
recovery, even in patients with preoperative LV dysfunction. (J Thorac Cardiovasc Surg 2014;148:1978-82)Mitral valve (MV) repair has become the standard
therapy for severe degenerative mitral regurgitation (MR)
because valve replacement is associated with greater
postoperative mortality than valve repair.1-4 The current
American College of Cardiology (ACC)/American Heart
Association (AHA) guidelines recommend MV surgery
in the presence of left ventricular (LV) dysfunction (LV
ejection fraction [LVEF] <60%) or dilatation (LV
end-systolic dimension [LVESD]>40 mm).5 These thresh-
olds were determined in previous studies of postoperative
survival, but with less assessment of postoperative LV
function.6-13 Recently, MV repair has become more
aggressively indicated for asymptomatic severe MR
without LV deterioration.14,15 Surgical intervention for
asymptomatic patients should provide not only better
postoperative survival but also maintenance of LV
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The Journal of Thoracic and Cardiovascular Surhas a poor prognosis.6-8 In contrast, many patients have
already developed LV deterioration when first diagnosed
with severe MR and some patients undergoing relatively
late surgery recover their LV function postoperatively.
This study aimed to identify the factors that predict
favorable long-term postoperative LV function.METHODS
Study Population
This study was a retrospective review of the medical records of
consecutive patients who underwent MV surgery for severe MR in our
institution between 1996 and 2010. We reviewed the preoperative and
long-term postoperative echocardiographic data of 473 patients who
underwent successful MV repair for severe degenerative MR. Patients
with a previous history of cardiac surgery or active endocarditis were
excluded. Baseline patient characteristics and preoperative and postopera-
tive echocardiographic data of these 473 patients were evaluated.
Surgical Procedures
All operations were performed by an experienced surgeon using
simplified and reproducible techniques. After assessing the complete mitral
apparatus, quadrangular or triangular resection was performed if the
posterior leaflet was redundant and prolapsed. The height of the remaining
posterior leaflet was reduced to less than 15 mm using a sliding technique
or folding procedure, if necessary. Chordal reconstruction with expanded
polytetrafluoroethylene was performed to repair the anterior leaflet. Ring
annuloplasty was routinely performed using a flexible complete ring or a
band. Intraoperative transesophageal echocardiography was routinely
performed to evaluate residual regurgitation. Successful repair was definedgery c November 2014
Abbreviations and Acronyms
AF ¼ atrial fibrillation
AHA ¼ American heart Association
CI ¼ confidence interval
LV ¼ left ventricular
LVEF ¼ left ventricular ejection fraction
LVESD ¼ left ventricular end-systolic dimension
MR ¼ mitral regurgitation
MV ¼ mitral valve
NYHA ¼ New York Heart Association
RVSP ¼ right ventricular systolic pressure
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Dby a maximum area of residual regurgitation of 2 cm2 or less on
intraoperative transesophageal echocardiography, and the absence of a
regurgitant jet impinging on the ring. In the case of an unsuccessful repair,
a second pump run was initiated for re-repair.
Echocardiographic Evaluation
Echocardiographic data were analyzed preoperatively and 3 years
postoperatively. Two-dimensional echocardiography and Doppler color
flow imaging were performed in all patients. LV dimensions were acquired
in the parasternal long-axis view and LVEFwasmeasured using the biplane
Simpson disk method.16 Quantification and severity grading of MR was
based on the current guidelines.5 Right ventricular systolic pressure
(RVSP) was estimated using continuous-wave Doppler and the simplified
Bernoulli equation of tricuspid regurgitation peak velocity.17
Statistical Analysis
Categorical variables are presented as number and percent, and these
were compared using the c2 test or Fisher exact test, as appropriate.
Continuous variables are described as the mean  standard deviation.
Survival analysis was performed by Kaplan-Meier analysis and differences
between groups were tested using the log-rank test. To determine the
predictors of long-term postoperative LV dysfunction, the Cox proportional
hazards model was used to estimate the risks associated with the following
variables: age, gender, portion of prolapsed mitral leaflet, LVESD, LVEF,
atrial fibrillation (AF), moderate or higher postoperative residual MR,
and RVSP. Log(time) versus log[log (survival)] stratified by each
significant risk factor was plotted and the relative slopes of the plotted lines
were evaluated. Those variables for which probability values were less than
.20 in univariable analyses and where proportional assumptions were
generally fair were included in the multivariable analysis. For
additional comparison of the prognostic value of preoperative LVESD
and LVEF for long-term postoperative LV dysfunction, receiver operating
characteristic curves were generated and the areas under the curves were
calculated. All analyses were performed with the statistical software
program JMP 7.02 (SAS Institute, Inc, Cary, NC).RESULTS
Baseline Patient Characteristics and Preoperative
Echocardiography
The clinical features of the 473 patients enrolled in this
study are summarized in Table 1. There were 261 (55%)
men and 212 (45%) women with a mean age of 57  14
years. Preoperative transthoracic echocardiography was
performed within a month before surgery in all patients.The Journal of Thoracic and CarThe mean LVEF was 64%  10% and preoperative LV
dysfunction, defined as LVEF less than 60% was seen in
139 patients (29%). The mean LVESD was 35  8 mm
and preoperative LV dilatation, defined as LVESD greater
than 40 mm was seen in 133 patients (28%). AF was
detected in 138 patients (29%) and pulmonary hyperten-
sion, defined as estimated RVSP greater than 50 mm Hg
was found in 89 patients (19%).
Surgical Procedure and 3-Year Postoperative
Echocardiography
Surgical procedure and 3-year postoperative echocardio-
graphy data are shown in Table 1. Portions of prolapsed
leaflets were anterior in 111 (23.5%), posterior in 247
(52.2%), and bileaflet in 115 (24.3%). Artificial chordal
replacement was performed in almost half of the patients
and ring annuloplasty was preformed in almost all
patients. MV repair was successfully performed in all
patients, including 26 patients (5%) who required a second
pump run and re-repair. Fourteen patients (3%) had residual
MR (moderate or greater) at postoperative echocardiography
within 3months after surgery, and thiswere not related to the
portion of prolapsed leaflet. Three years after surgery, both
LVEF and LVESD were significantly decreased compared
with preoperative data (P<.001 for both parameters). Recur-
rentMR (moderate or greater)was seen in 48 patients (10%),
and in patients with anterior or bileaflet prolapse the rate
of recurrent MR was significantly higher compared with
those with isolated posterior leaflet prolapse (14% vs 6%,
P ¼ .006). However, there was no significant correlation
between recurrent MR and LV dysfunction after 3 years.
Predictors of Long-Term Postoperative LV
Dysfunction
A total of 45 patients (10%) showed LV dysfunction,
defined as LVEF less than 50% at 3-year postoperative
echocardiography. Table 2 shows the results of multivariate
analyses for predictors of long-term postoperative LV
dysfunction. Using multivariate analysis, preoperative
LVEF (odds ratio, 0.93; 95% confidence interval [CI],
0.90-0.96; P< .001) and LVESD (odds ratio, 1.11; 95%
CI, 1.05-1.17; P< .001) were confirmed as independent
predictors of long-term postoperative LV dysfunction
(Table 2). Receiver operating characteristic curve analysis
identified LVEF 63% or less (area under the curve, 0.725;
95% CI, 0.652-0.798; P < .001) and LVESD 39 mm
or greater (area under the curve, 0.724; 95% CI, 0.650-
0.799; P<.001) as cut-off values for predicting long-term
postoperative LV dysfunction.
Preoperative LV Parameter and Long-Term
Postoperative LV Dysfunction
Patients were assigned to 1 of the 4 groups, according
to their preoperative LVEF (> or 63%), and LVESDdiovascular Surgery c Volume 148, Number 5 1979
TABLE 1. Patient characteristics, surgical procedures, and
echocardiographic indices
All (n ¼ 473)
Mean age, y  SD 57  14
Male, n (%) 261 (55)
Body surface area, m2  SD 1.59  0.19
Atrial fibrillation, n (%) 138 (29)
Portion of prolapsed leaflet, n (%)
Anterior leaflet 111 (23.5)
Posterior leaflet 247 (52.2)
Bileaflet 115 (24.3)
Surgical procedure, n (%)
Resection and suture technique 408 (86)
Artificial chordal replacement 226 (48)
Ring annuloplasty 421 (89)
Second pump 26 (5)
Preoperative echocardiographic indices
LV ejection fraction,%  SD 64  10
LV end-diastolic dimension, mm  SD 56  8
LV end-systolic dimension, mm  SD 35  8
Left atrial dimension, mm  SD 47  9
Right ventricular systolic pressure, mm Hg  SD 44  15
Echocardiographic indices 3-y after surgery
LV ejection fraction,%  SD 60  9
LV end-diastolic dimension, mm  SD 46  6
LV end-systolic dimension, mm  SD 30  7
Left atrial dimension, mm  SD 42  9
Right ventricular systolic pressure, mm Hg  SD 35  16
Recurrent mitral regurgitation, n (%)
None or trivial 282 (55)
Mild 163 (35)
Moderate 42 (9)
Severe 6 (1)
SD, Standard deviation; LV, left ventricular.
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D( or<39 mm) as follows: group A (n ¼ 240), LVEF
greater than 63% and LVESD less than 39 mm; group B
(n ¼ 85), LVEF 63% or less and LVESD less than 39
mm; group C (n¼ 47), LVEF greater than 63% and LVESD
39 mm or greater; group D (n ¼ 101), LVEF 63% or lessTABLE 2. Multivariable analysis of predictors of 3-year postoperative lef
All patients
OR (95% CI) P*
Age 1.03 (1.00-1.07) .03
Male — —
NYHA class>2 1.54 (0.76-3.10) .23
Preoperative echocardiographic indices
LV ejection fraction 0.93 (0.90-0.96) <.001
LV end-systolic dimension 1.11 (1.05-1.17) <.001
Atrial fibrillation 2.56 (1.26-5.33) .01
RVSP 50 mm Hg — —
Anterior or bileaflet prolapse — —
Postoperative residual MR (moderate) 2.12 (0.42-8.27) .33
OR, Odds ratio; CI, confidence interval; NYHA, New York Heart Association; LV, lef
*Cox proportional hazard model analysis.
1980 The Journal of Thoracic and Cardiovascular Surand LVESD 39 mm or greater (Figure 1). Figure 2 shows
the incidence of postoperative LV dysfunction among the
4 groups. Patients in group A had a significantly lower
incidence of long-term postoperative LV dysfunction
(group A vs B vs C vs D: 2% vs 9% vs 15% vs 25%;
P < .001). On multivariate analysis, both preoperative
LVEF and LVESD were not significant predictors of
long-term postoperative LV dysfunction among patients
with preoperative LVEF greater than 63% and LVESD
less than 39 mm (group A), whereas preoperative LVESD
(odds ratio, 2.22; P ¼ .004), higher age (odds ratio, 1.03;
P ¼ .04), and AF (odds ratio, 2.68; P ¼ .01) were indepen-
dent predictors among patients with preoperative LVEF
63% or less or LVESD 39 mm or greater (groups B-D)
(Table 2).DISCUSSION
The main findings of this study were as follows:
(1) preoperative LVEF 63% and LVESD 39 mm were the
best cut-off values to preserve LV function 3 years after
surgery; (2) predictors of long-term postoperative LV
dysfunction were LVESD, higher age, and AF in patients
with preexisting LV deterioration.
As degenerative valve disorders increase in frequency
as the population ages, myxomatous degenerative MV
disease is the most common cause of MR requiring surgery.
Surgical strategies for MR have shifted from MV replace-
ment to MV repair in recent decades because of evidence
supporting the advantages of repair for the preservation of
LV function and a lower risk for adverse events after
surgery. Although controversy remains regarding early
surgery for asymptomatic patients with severe MR without
LV dilatation/dysfunction, AF, and pulmonary hyperten-
sion, the current ACC/AHA guidelines recommended
surgery if MV repair is feasible.5 The rationale for surgery
is based on evidence of not only long-term survival but
also superior durability of a repaired valve and better
postoperative LV function. However, previous studiest ventricular dysfunction
Group A Groups B-D
OR (95% CI) P* OR (95% CI) P*
— — 1.03 (1.00-1.07) .04
— — — —
— — 1.84 (0.86-3.94) .11
0.98 (0.79-1.17) .85 0.99 (0.95-1.04) .79
1.04 (0.87-1.31) .67 2.22 (1.29-3.97) .004
— — 2.68 (1.22-6.11) .01
— — — —
— — — —
— — — —
t ventricular; RVSP, right ventricular systolic pressure; MR, mitral regurgitation.
gery c November 2014
FIGURE 1. Classification and incidence of postoperative left ventricular
dysfunction in 473 patients based on preoperative LVEF (>or63%) and
LVESD ( or<39 mm). LVEF, Left ventricular ejection fraction; LVESD,
left ventricular end-systolic dimension.
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degenerative MR often focused mainly on patients’
postoperative survival or the durability of the repaired
MV. Therefore, there are few data regarding the threshold
of LV size and function for the optimal timing of surgical
intervention to preserve or recover long-term postoperative
LV function.6,7,9,13 The threshold of LV size and function
determined in the present study support early surgery for
severe degenerative MR without LV dysfunction or
dilatation. Suri and colleagues11 reported LVEF greater
than 65% and LVESD less than 36 mm were the ideal
cut-off values for predicting postoperative LVEF of 50%
or more.11 These thresholds were similar to our findings;
however, their study included a significant numbers ofFIGURE 2. Proportion of postoperative LV dysfunction among the
4 subgroups: group A, LVEF>63% and LVESD<39 mm; group B,
LVEF >63% and LVESD 39 mm; group C, LVEF 63% and
LVESD<39 mm; group D, LVEF 63% and LVESD 39 mm. LV, Left
ventricular.
The Journal of Thoracic and Carpatients who underwent MV replacement. Echocardio-
graphic assessment of myocardial strain or exercise stress
echocardiography might be helpful to detect underlying
LV dysfunction even in patients with normal preoperative
LVEF and LVESD.18
Clinically, it is not unusual for patients to have
established LV dysfunction or dilatation when they are
first diagnosed with severe MR. Although guidelines
recommend surgery for these patients, reported postopera-
tive outcomes are worse than in patients who undergo
surgery before LV deterioration and some patients do
recover their LV function after surgery and some patients
worsen. There are also few data describing postoperative
LV function in patients with preoperative LV deterioration.
In the present study, although 283 patients had preoperative
LV deterioration, 428 patients had preserved LV function
postoperatively. Smaller LVESD, younger age, and sinus
rhythm were identified as determinants of preserved LV
function after surgery. These results indicate that surgical
intervention should be considered as soon as possible for
patients with preexisting LV deterioration, especially before
AF develops.
The main limitation of the present study is the retrospec-
tive design, which is prone to inherent bias, and decisions
regarding the timing of surgical intervention were not based
on a prospective randomized assignment. In addition, the
study was performed in a single center, which leads to
limitations in the generalization of the results.
CONCLUSIONS
Early MV repair with LVEF greater than 63% and
LVESD less than 39 mm preserved postoperative LV
function well, and smaller preoperative LVESD was
associated with long-term postoperative LV functional
recovery even in patients with preoperative LV dysfunction
undergoing surgery.
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